ArticleACS omega2021
Synthesis of Ultrastable and Bioconjugable Ag, Au, and Bimetallic Ag_Au Nanoparticles Coated with Calix[4]arenes.
Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 32 citations in OpenAlex.
- Recent advances of silver nanoparticle-based polymer nanocomposites for biomedical applications.RSC advances · 2025Review
- Mechanism of hierarchical plasmonic biomaterials engineered through peptide-directed self-assembly.Aggregate (Hoboken, N.J.) · 2025Article
- Multiplexed immunolabelling of cancer using bioconjugated plasmonic gold-silver alloy nanoparticles.Nanoscale advances · 2024Article
- Article
- A Protease-Responsive Polymer/Peptide Conjugate and Reversible Assembly of Silver Clusters for the Detection ofACS nano · 2023Article
- Empirical Optimization of Peptide Sequence and Nanoparticle Colloidal Stability: The Impact of Surface Ligands and Implications for Colorimetric Sensing.ACS applied materials & interfaces · 2023Article
- A fluoride-induced aggregation test to quickly assess the efficiency of ligand exchange procedures from citrate capped AuNPs.Colloids and surfaces. A, Physicochemical and engineering aspects · 2023Article
- Di-Arginine Additives for Dissociation of Gold Nanoparticle Aggregates: A Matrix-Insensitive Approach with Applications in Protease Detection.ACS applied materials & interfaces · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Compared to gold nanoparticles, silver nanoparticles are largely underexploited for the development of plasmonic nanosensors. This is mainly due to their easy chemical degradation through oxidation, poor colloidal stability, and usually broad size distribution after synthesis, which leads to broad localized surface plasmon resonance bands. Coatings based on polymers such as poly(ethylene glycol) (PEG) or poly(vinylpyrrolidone) (PVP) and plant extracts have been used for the stabilization of AgNPs; however, these thick coatings are not suitable for sensing applications as they isolate the metallic core. The examples of stable AgNPs coated with a thin organic layer remain scarce in comparison to their gold counterparts. In this work, we present a convenient one-step synthesis strategy that allows to obtain unique gold, silver, and bimetallic NPs that combine all of the properties required for biosensing applications. The NPs are stabilized by a tunable calix[4]arene-based monolayer obtained through the reduction of calix[4]arene-tetradiazonium salts. These multidentate ligands are of particular interest as (i) they provide excellent colloidal and chemical stabilities to the particles thanks to their anchoring to the surface via multiple chemical bonds, (ii) they allow the subsequent (bio)conjugation of (bio)molecules under mild conditions, and (iii) they allow a control over the composition of mixed coating layers. Ag and Ag_Au nanoparticles of a high stability are obtained, opening perspectives for development of numerous biosensing applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.